Latest reviews have demonstrated that transcription of the DEK oncogene is up-regulated in breast cancers with particularly robust gene expression detected in lymph node constructive and late stage breast cancers, and that DEK expression correlated with improved recurrence costs
Ongoing advancements in our comprehending of the biology of these cancers are critical in purchase to create novel, much more powerful and possibly combinatorial therapies. Latest stories have revealed that…